![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Beard R. W., Highman J. W., Pearce S., Reginald P. W. Diagnosis of pelvic varicosities in women with chronic pelvic pain. Lancet 1984; ii: 946–949
- Beard R. W., Kennedy R. W., Gangar K. F., Stones R. W., Rogers V., Reginald P. W., Anderson M. Bilateral oophorectomy and hysterectomy in the treatment of intractable pelvic pain associated with pelvic congestion. British Journal of Obstetrics and Gynaecology 1991; 98: 988–992
- Casson P., Hahn P. M., Van Vugt D. A., Reid R. L. Lasting response to ovariectomy in severe intractable premenstrual syndrome. American Journal of Obstetrics and Gynecology 1990; 162: 99–105
- Colditz G. A., Willett W. C., Stampfer M. J., Rosner B., Speizer F. E., Hennekens C. H. Menopause and the risk of coronary heart disease in women. New England Journal of Medicine 1987; 316: 1105–1110
- Gangar K., Cust M., Whitehead M. I. Symptoms of oestrogen deficiency associated with supra-physiological plasma oestradiol concentrations in women with oestradiol implants. British Medical Journal 1989; 299: 601–602
- Hahn L. Clinical findings and results of operative treatment in ilioinguinal nerve entrapment syndrome. British Journal of Obstetrics and Gynaecology 1989; 96: 1080–1083
- Huskisson E. C. Measurement of pain. Lancet 1974; ii: 1127–1131
- Lindsay R., Hart D. M., Forrest C., Baird C. Prevention of spinal osteoporosis in oophorectomised women. Lancet 1980; ii: 1151–1154
- Rosenberg L., Hennekens C. H., Rosner B., Belanger C., Rothman K. J., Speizer F. E. Early menopause and the risk of myocardial infarction. American Journal of Obstetrics and Gynaecology 1981; 139: 47–51
- Seeley T. Oestrogen replacement therapy after hysterectomy. British Medical Journal 1992; 305: 811–812
- Siddall-Allum J., Rae T., Rogers V., Witherow R., Flanagan A., Beard R. W. Chronic pelvic pain caused by residual ovaries and ovarian remnants. British Journal of Obstetrics and Gynaecology 1994; 101: 979–985
- Spector T. D. Use of oestrogen replacement therapy in high risk groups in the United Kingdom. British Medical Journal 1989; 299: 1434–1435
- Stevenson J. C., Cust M., Gangar K. E., Hillard T. C., Lees B., Whitehead M. I. Effects of trans-dermal versus oral hormone replacement therapy on bone density in spine and proximal femur in post-menopausal women. Lancet 1990; 336: 265–269
- West C. P. Endometriosis. British Medical Journal 1990; 301: 189–190